142 related articles for article (PubMed ID: 9689292)
1. Skin irritation by dithranol cream. A blind study to assess the role of the cream formulation.
Prins M; Swinkels OQ; Kolkman EG; Wuis EW; Hekster YA; van der Valk PG
Acta Derm Venereol; 1998 Jul; 78(4):262-5. PubMed ID: 9689292
[TBL] [Abstract][Full Text] [Related]
2. The effects of topical corticosteroids and a coal tar preparation on dithranol-induced irritation in patients with psoriasis.
Swinkels OQ; Kucharekova M; Prins M; Gerritsen MJ; van der Valk PG; van de Kerkhof PC
Skin Pharmacol Appl Skin Physiol; 2003; 16(1):12-7. PubMed ID: 12566824
[TBL] [Abstract][Full Text] [Related]
3. Dithranol in a cream preparation: disperse or dissolve?
Prins M; Swinkels OQ; Bouwhuis S; de Gast MJ; Bouwman-Boer Y; van der Valk PG; van de Kerkhof PC
Skin Pharmacol Appl Skin Physiol; 2000; 13(5):273-9. PubMed ID: 10940817
[TBL] [Abstract][Full Text] [Related]
4. Transepidermal water vapour loss is not increased during and following dithranol irritation.
Snater E; Janssen EA; van der Valk PG; van de Kerkhof PC
Br J Dermatol; 1995 Jun; 132(6):908-12. PubMed ID: 7662568
[TBL] [Abstract][Full Text] [Related]
5. Skin susceptibility to dithranol: contact allergy or irritation?
Loffler H; Effendy I; Happle R
Eur J Dermatol; 1999; 9(1):32-4. PubMed ID: 9920984
[TBL] [Abstract][Full Text] [Related]
6. Irritation and staining by dithranol (anthralin) and related compounds. III. Cumulative irritancy and staining during repeated chamber testing.
Brandt H; Mustakallio KK
Acta Derm Venereol; 1983; 63(3):237-40. PubMed ID: 6192640
[TBL] [Abstract][Full Text] [Related]
7. The efficacy, safety and tolerance of calcitriol 3 microg/g ointment in the treatment of plaque psoriasis: a comparison with short-contact dithranol.
Hutchinson PE; Marks R; White J
Dermatology; 2000; 201(2):139-45. PubMed ID: 11053917
[TBL] [Abstract][Full Text] [Related]
8. Ultrasound description and quantification of irritant reactions induced by dithranol at different concentrations. A comparison with visual assessment and colorimetric measurements.
Schiavi ME; Belletti B; Seidenari S
Contact Dermatitis; 1996 Apr; 34(4):272-7. PubMed ID: 8730166
[TBL] [Abstract][Full Text] [Related]
9. The influence of a topical corticosteroid on short-contact high-dose dithranol therapy.
Swinkels OQ; Prins M; Tosserams EF; Gerritsen MJ; Van Der Valk PG; Van De Kerkhof PC
Br J Dermatol; 2001 Jul; 145(1):63-9. PubMed ID: 11453908
[TBL] [Abstract][Full Text] [Related]
10. Irritation and staining by dithranol (anthralin) and related compounds. V. Short-contact and tape-stripping experiments with dithranol and butantrone.
Göransson AM; Kolari PJ; Mustakallio KK
Acta Derm Venereol; 1984; 64(2):134-9. PubMed ID: 6203301
[TBL] [Abstract][Full Text] [Related]
11. A randomized, double-blind, vehicle-controlled study of a novel liposomal dithranol formulation in psoriasis.
Saraswat A; Agarwal R; Katare OP; Kaur I; Kumar B
J Dermatolog Treat; 2007; 18(1):40-5. PubMed ID: 17365266
[TBL] [Abstract][Full Text] [Related]
12. Dithranol irritation in psoriasis treatment: a study of 68 inpatients.
Kucharekova M; Lieffers L; van de Kerkhof PC; van der Valk PG
J Eur Acad Dermatol Venereol; 2005 Mar; 19(2):176-9. PubMed ID: 15752286
[TBL] [Abstract][Full Text] [Related]
13. Treatment of psoriasis with dithranol cream compared with dithranol paste.
Young E
Dermatologica; 1986; 173(6):285-7. PubMed ID: 3817239
[TBL] [Abstract][Full Text] [Related]
14. A comparison of twice-daily calcipotriol ointment with once-daily short-contact dithranol cream therapy: a randomized controlled trial of supervised treatment of psoriasis vulgaris in a day-care setting.
van de Kerkhof PC; van der Valk PG; Swinkels OQ; Kucharekova M; de Rie MA; de Vries HJ; Damstra R; Oranje AP; de Waard-van der Spek FB; van Neer P; Lijnen RL; Kunkeler AC; van Hees C; Haertlein NG; Hol CW
Br J Dermatol; 2006 Oct; 155(4):800-7. PubMed ID: 16965431
[TBL] [Abstract][Full Text] [Related]
15. Dithranol embedded in crystalline monoglycerides combined with phototherapy (UVB): a new approach in the treatment of psoriasis.
Gerritsen MJ; Boezeman JB; Elbers ME; van de Kerkhof PC
Skin Pharmacol Appl Skin Physiol; 1998; 11(3):133-9. PubMed ID: 9745140
[TBL] [Abstract][Full Text] [Related]
16. The response of uninvolved skin of patients with psoriasis to single and repeated applications of dithranol cream: an immunohistochemical assessment.
Swinkels OQ; Prins M; van Vlijmen-Willems IM; Gerritsen MJ; van der Valk PG; van de Kerkhof PC
Skin Pharmacol Appl Skin Physiol; 2002; 15(6):385-92. PubMed ID: 12476012
[TBL] [Abstract][Full Text] [Related]
17. A novelliposomal formulation of dithranol for psoriasis: preliminary results.
Agarwal R; Saraswat A; Kaur I; Katare OP; Kumar B
J Dermatol; 2002 Aug; 29(8):529-32. PubMed ID: 12227489
[TBL] [Abstract][Full Text] [Related]
18. In vitro and in vivo comparison of creams containing dithranol 0.5%.
Ros JJ; Van der Meer YG; De Hoop D; De Kort WJ; Van Andel P
Pharm Weekbl Sci; 1991 Oct; 13(5):210-4. PubMed ID: 1749710
[TBL] [Abstract][Full Text] [Related]
19. [Dithranol in the treatment of scalp psoriasis].
Haas N; Wulff-Woesten A; Sterry W; Meffert H
J Dtsch Dermatol Ges; 2003 Sep; 1(9):688-93. PubMed ID: 16285275
[TBL] [Abstract][Full Text] [Related]
20. Treatment of chronic plaque psoriasis with dithranol and urea creams: a double-blind study.
Young MM
Pharmatherapeutica; 1982; 3(2):86-92. PubMed ID: 7048339
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
